Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853605 · ClinicalTrials.gov registry record · NA
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
A NA study, sponsored by Allergan.
- Terminated
- Registry status
- NA
- Development phase
- 3,811
- Enrollment target
NCT01853605 is a NA study that was terminated before completion, run by Allergan. The registered enrollment target is 3,811 participants.
The verdict
NCT01853605, a NA study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- NA
- Development phase
- 3,811 participants
- Enrollment target
Study Summary
Post-approval study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (Styles 410 FM, FF, MM, or MF) for breast augmentation, reconstruction, or revision
Interventions
- DEVICE Anatomically shaped silicone gel-filled breast implants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,811 participants |
| Start Date | 2003-04 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853605
The ClinicalTrials.gov registry entry for NCT01853605 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3,811 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anatomically shaped silicone gel-filled breast implants is the first listed.
NCT01853605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01853605 about?
NCT01853605 is a clinical study titled "NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study". Post-approval study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (Styles 410 FM, FF, MM, or MF) for breast augmentation, reconstruction, or revision
What is the current status of trial NCT01853605?
This trial is currently terminated. It is a NA study. The enrollment target is 3,811 participants. The study started on 2003-04. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01853605?
The interventions under investigation include: Anatomically shaped silicone gel-filled breast implants (DEVICE).
Who is sponsoring clinical trial NCT01853605?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.